Could 2022 be the year brain computing tech picks up in healthcare? The market is forecast to hit $3.5B by 2027. We detail how clinical trials could yield new applications to treat epilepsy, communication disorders, and spinal cord injuries.
Here are this week's hottest digital health startups: : Everside Health scores $164M, Health Note nabs $17M.
We explore why Teladoc’s Q2 earnings loss raises question about the Livongo acquisition and detail what the results foreshadow for the US telehealth market.
AI reads the operating room: Surgeries may soon be under AI surveillance as startup Theator expands its video analytics to operating rooms. It could yield helpful insights as well as controversy.
Health systems huddle up on predictive medicine: We detail why large health systems like Mayo Clinic and Mercy are collaborating to advance disease detection.
Digital therapeutics and EHRs go hand in hand: We discuss how a new AmerisourceBergen platform will make e-prescribing DTx through EHRs easier.
Robopill awaits clinical trials…and patient approval: Endiatx’s robotic pill could make medical procedures less invasive, but earning public trust may be difficult. Preempting concerns with transparency could help.
Patients still distrust Big Tech and health tech companies with their data: We unpack the implications around Big Tech health data access, Roe vs. Wade issues and healthcare literacy on the back of a new AMA survey.
Cadence enters the life science market to revolutionize drug discovery: Its OpenEye Scientific acquisition is an example of pharma’s investment in biosimulations for therapeutic research.
We detail why layoffs are only the tip of the iceberg for health tech companies like it this year.
A call for talent in revenue cycle management: We take a look at how companies are hiring for RCM and the role that RCM software adoption will play in addressing the labor shortage.
FDA approves clinical wearable that detects atrial fibrillation: We unpack what the news means for managing cardiac conditions.
PLUS: We predict where Amazon is headed next